Cite
MLA Citation
Ewelina Kulikowski et al.. “Apabetalone (RVX-208) may lower CVD events in diabetes mellitus by affecting complement pathway and microbiome activity.” Atherosclerosis, vol. 263, 2017, pp. e113–. http://access.bl.uk/ark:/81055/vdc_100048161467.0x000010